Publications

First-in-Human Phase I/II Study of CYT-0851 in Patients with Advanced Solid and Hematologic
Lynch, R.C., et.al., ASCO 2021
VIEW PUBLICATION →

Phase 1 Results of CYT-0851 in Patients with Advanced Solid and Hematologic Cancers
Lynch, R.C., et.al., ASCO 2022
VIEW PUBLICATION →

Identification of the Mechanism of Action of CYT-0851, An Inhibitor of Monocarboxylate Transporter (MCT) Mediated Lactate Transport
Bradley, W.D., et.al., 34th EORTC-NCI-AACR Symposium 2022
VIEW PUBLICATION →